AzTrials
AzTrials

tDCSNCT07839910

Wearable tDCS and Acute Golf Shot Performance

A study testing Wearable transcranial direct current stimulation (Halo Sport 2) in people with tDCS and Golf Specific Performance, run by Shanghai University of Sport at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Transcranial direct current stimulation (tDCS) has been investigated as an ergogenic aid for two decades, but most sport evidence comes from laboratory stimulators operated by experimenters. Read more about this study

Who is it for?
Ages 16 years and olderHealthy volunteers can take part
What is being tested?
Wearable transcranial direct current stimulation (Halo Sport 2)
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
67 participants
Where
1 siteChina
Study dates
1 May 2025to 31 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Age ≥ 16 years;
  • at least 2 years of systematic golf training;
  • own set of clubs covering the standardized test clubs;
  • right-handedness;
  • normal or corrected-to-normal vision;
  • no musculoskeletal injury in the previous 6 months that would affect the golf swing.

Who cannot join

  • History of neurological or psychiatric disease; epilepsy;
  • metal implants in the head; pregnancy;
  • skin lesions under the electrode sites;
  • current use of central-nervous-system-active medication;
  • migraine within the previous year.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Shanghai University of Sport, School of Physical Education

    Shanghai, Shanghai Municipality, 200438

Other trials in China

About this study

Official title: Skill-dependent Acute Effects of Wearable Transcranial Direct Current Stimulation on Golf Shot Performance: a Double-blind, Sham-controlled Randomized Trial

Transcranial direct current stimulation (tDCS) has been investigated as an ergogenic aid for two decades, but most sport evidence comes from laboratory stimulators operated by experimenters. This trial evaluates whether a single 20-minute session of wearable, app-controlled bilateral motor-cortex tDCS (Halo Sport 2, 2 mA) improves full-swing golf shot performance compared with sham stimulation. The study is a double-blind, sham-controlled, parallel-group randomized trial with a pre-test/post-test design in golfers stratified into professional, amateur-high, and amateur-middle skill groups. Each participant attends a single session comprising a 40-shot pre-test, 20 minutes of real or sham stimulation, and a 40-shot post-test, with shots measured by a TrackMan 4 launch monitor across eight standardized club categories. The primary outcomes are change scores (post minus pre) in carry distance, ball speed, smash factor, within-player carry-distance variability, and absolute lateral deviation. Effects will be examined overall and as a function of skill level (categorical group and continuous golf handicap).

Read the detailed description

Participants are stratified by skill level (professional, amateur-high, amateur-middle) and sex, and randomly assigned 1:1 to real or sham stimulation using a computer-generated sequence; allocation is concealed from the testing team. Real stimulation: Halo Sport 2 headset, bilateral primary motor cortex (approximately C3/C4), 2 mA for 20 minutes (30-s ramp up and down), controlled by smartphone app. Sham: identical device and app procedure with a 30-s current ramp-up followed immediately by ramp-down and no sustained current; the app does not display the stimulation mode. Each participant attends one session: 10-min standardized warm-up, 40-shot pre-test, 20-min stimulation, 40-shot post-test. Shot outcomes (carry distance, ball speed, smash factor, spin rate, launch angle, launch direction, club speed, attack angle, face-to-path) are recorded with a TrackMan 4 launch monitor; within-player variability (SD of five shots) is computed per club category (Driver, 3-wood, hybrid, 5-iron, 7-iron, 9-iron, 70-yd wedge task, 100-yd wedge task). Analyses use linear mixed models with likelihood-ratio tests; skill-dependent moderation is tested categorically (group) and continuously (handicap linear and quadratic interactions) with false-discovery-rate correction. Anonymized participant-level data and analysis scripts will be made available in a public repository (Zenodo, https://doi.org/10.5281/zenodo.22684611).

Being tested
Wearable transcranial direct current stimulation (Halo Sport 2)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Wearable transcranial direct current stimulation (Halo Sport 2)Behavioural

    Participants stratified by skill group (professional / amateur-high / amateur-middle) and sex, then randomly assigned 1:1 to real or sham stimulation

Study groups in NCT07839910
Study groupRoleWhat they receive
Real tDCSExperimentalHalo Sport 2 wearable headset; bilateral primary motor cortex (approx. C3/C4); 2 mA; 20 min (30-s ramp up/down); single session between pre- and post-test; app-controlled
Receives: Behavioral: Wearable transcranial direct current stimulation (Halo Sport 2)
Sham tDCSSham comparatorSame device and app; 30-s ramp-up followed immediately by ramp-down; no sustained current
Receives: Behavioral: Wearable transcranial direct current stimulation (Halo Sport 2)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Carry distance change

    Post minus pre carry distance (yards), per club category

    Measured: Baseline and immediately after intervention (same-day single session)

  2. Ball speed change

    Post minus pre ball speed (mph), per club category

    Measured: Baseline and immediately after intervention (same-day single session)

  3. Smash factor change

    Post minus pre smash factor (ball speed / club speed), per club category

    Measured: Baseline and immediately after intervention (same-day single session)

  4. Carry distance variability change

    Post minus pre within-player SD of the five shots per club category (yards)

    Measured: Baseline and immediately after intervention (same-day single session)

  5. Absolute lateral deviation change

    Post minus pre absolute carry-side deviation (yards), per club category |

    Measured: Baseline and immediately after intervention (same-day single session)

Secondary outcomes (8)
  1. Total distance change

    Measured: Baseline and immediately after intervention (same-day single session)

  2. Spin rate change

    Measured: Baseline and immediately after intervention (same-day single session)

  3. Launch angle change

    Measured: Baseline and immediately after intervention (same-day single session)

  4. Absolute face-to-path change

    Measured: Baseline and immediately after intervention (same-day single session)

  5. Absolute launch direction change

    Measured: Baseline and immediately after intervention (same-day single session)

  6. Club head speed change

    Measured: Baseline and immediately after intervention (same-day single session)

  7. Attack angle change

    Measured: Baseline and immediately after intervention (same-day single session)

  8. Ball speed variability change(within-player SD of five shots)

    Measured: Baseline and immediately after intervention (same-day single session)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Sep 2026
  2. Study start1 May 2025
  3. Primary completion31 Dec 2025
  4. Study completion31 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
67 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07839910
Sponsor's protocol ID
102772025RT109
Status last verified
Sep 2026
First submitted
14 Sep 2026
Last updated
24 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Anonymized participant-level dataset and analysis scripts

Questions about this trial

What is this clinical trial studying?

A study testing Wearable transcranial direct current stimulation (Halo Sport 2) in people with tDCS and Golf Specific Performance, run by Shanghai University of Sport at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Carry distance change (time frame: Baseline and immediately after intervention (same-day single session)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in